Scientists have developed a computer-based model that may explain how nerve cells become damaged in ALS, and how best to time ...

Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no cure and limited treatment options. One of the earliest signs of ALS is overactive brain signals known as ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...

It's a terminal disease, currently with no cure. ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully ...

DURHAM -- August is the month the Ice Bucket Challenge kicks off, and Tuesday the Duke ALS Clinic joined in with an Ice Bucket Challenge of its own. The director of the clinic and leading ALS ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Erik P Pioro consults for MT Pharma, which manufactures edaravone (Radicava) and for Biogen, which manufactures tofersen (Qalsody). He has received funding support for ALS research from the ALS ...

On Monday, the 52-year-old actor -- who revealed his diagnosis in April -- posted a video on Instagram in collaboration with the organization, I AM ALS, for its Push for Progress campaign, which hopes ...

The ALS Network’s 23rd annual Inland Empire Walk and Roll to Cure ALS, formerly the Walk to Defeat ALS, will be held Oct. 19 at Miller Park Amphitheater, 17002 Arrow Blvd., Fontana. The Walk and Roll ...